https://www.selleckchem.com/products/cm-4620.html
4 vs. 7.1%; = .001), with an adjusted HR of 2.16 (95%CI 1.25-3.75; = .006). Compared to high-income, low-income individuals had the worst clinical presentation of myocardial infarction and less frequently received dual antiplatelet therapy and statins at hospital discharge. The population attributable risk of low income was 44.8%. HDI and DCTH did not influence the delay to reperfusion therapy nor the risk of death. Low income was independently associated with a higher long-term mortality rate, lower prescription of guidelines-recommend